Evidence map›Paper›PMID 31114648›Full record

ArticleJournal of ophthalmic & vision research

Autologous Platelet-rich Plasma Eye Drops Accelerate Re-epithelialization of Post-keratoplasty Persistent Corneal Epithelial Defects.

Shaban Alizadeh, Sahar Balagholi, Alireza Baradaran-Rafii, Siamak Delfaza-Baher, Sare Safi, Hamid Safi, Rasul Dabbaghi, Mozhgan Rezaei Kanavi

Open access · goldAbstract read
In one paragraph

Article in Journal of ophthalmic & vision research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Shaban AlizadehDepartment of Hematology, School of Allied Medicine, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0001-6253-0822
Sahar BalagholiDepartment of Hematology, School of Allied Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Alireza Baradaran-RafiiOcular Tissue Engineering Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Siamak Delfaza-BaherOphthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Sare SafiOphthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Hamid SafiOphthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Rasul DabbaghiDepartment of Hematology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Mozhgan Rezaei KanaviOcular Tissue Engineering Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-1497-2260
Shahid Beheshti University of Medical Sciences · IRTarbiat Modares University · IRTehran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo investigate whether autologous platelet-rich plasma (PRP) eye drops accelerate re-epithelialization of post-keratoplasty persistent corneal epithelial defects (PEDs).

methodsA total of 34 eyes with PEDs after keratoplasty (24 penetrating keratoplasty and 10 deep anterior lamellar keratoplasty) that were refractory to conventional medical treatments were treated with PRP eye drops every 3 hours. PRP eye drops were prepared with a low- and high-speed centrifugation method and final platelet counts were 700,000-800,000 plt/μl. The mean treatment duration for complete re-epithelialization was compared with the mean treatment duration of conventionally treated corneal defects before the PRP treatment by paired

resultsTreatment with autologous PRP eye drops led to rapid re-epithelialization in all eyes. The mean treatment duration for complete re-epithelialization was 2.47 ± 1.21 weeks, which was significantly shorter than the mean treatment duration of conventionally treated corneal defects before PRP treatment (6.82 ± 1.24 weeks) (

conclusionTreatment with autologous PRP eye drops is an effective and reliable approach that accelerates re-epithelialization of post-transplantation PEDs.

Indexed as

Corneal Epithelial DefectsEye DropHealingKeratoplastyPEDPlatelet

Identifiers

PMID31114648
PMCPMC6504730
OpenAlexW2939860978

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.